MDL For Elmiron Eye Injuries Created, Assigned To New Jersey Federal Court

(December 16, 2020, 9:45 AM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 15 granted a plaintiffs’ motion to centralize 128 federal lawsuits alleging eye injuries caused by the bladder drug Elmiron in a multidistrict litigation in the U.S. District Court for the District of New Jersey (In Re:  Elmiron [Pentosan Polysulfate Sodium] Products Liability Litigation, MDL Docket No. 2973, JPMDL)....

Attached Documents

Related Sections